Profile: Unique Biotech Innovations LLC develops laboratory tests for the hospital market by commercializing blood coagulation products. We provide solutions to critical problems that affect millions of patients with blood coagulation disorders. We specialize in the development of diagnostic products for the coagulation market that are extremely stable. We offer activated partial thromboplastin reagent. Our aPTT is more sensitive to heparin and abnormal clotting test results. This allows detection of mild factor deficiencies in addition to increased sensitivity to heparin, which enables more effective treatment of these patients.